Title:
Have you contracted COVID-19 and are experiencing depression?
|
| What is the purpose of the study? |
| |
COVID-19 is thought to lead to depression by causing inflammation, the body's natural response to injury and infection, in the brain. We have developed a brain scan to detect inflammation and we have used it to study many different illnesses. In this study, we plan to use this scan to look at brain inflammation in those experiencing depression after contracting COVID-19. We hope that results from this study will lead to new treatments specifically for depression caused by inflammation.
|
| Who is needed? |
| |
Individuals with: |
past COVID-19, new onset depression |
| |
Individuals without
a mental health or
addiction problem:
|
Yes
|
| |
Age range: |
18 - 80 |
| |
Gender: |
All |
| |
Ethnicity: |
|
| |
Other:
|
|
| What does the study involve? |
| |
Number of contacts: |
1 phone call, 3 sessions at CAMH College Site |
| |
Time period: |
4 - 6 weeks |
| |
Length of contacts: |
20 min. phone call, 3 hour session, 8 hour session, 3 hour session |
| |
Treatment offered:
|
No
|
Location:
|
250 College St., Research Imaging Centre
|
Principal Investigator:
|
Dr. Jeffrey Meyer
|
| Contact information: |
| |
Phone: |
416-535-8501 ext. 30741 |
| |
e-mail: |
COVID19study@camh.ca |
| |
Website: |
|
| |
Flyer:
|
|
Study end date:
|
01 May 2023
|
| REB number: |
177/2020 |
| Full study title: |
Imaging Neuroinflammation in COVID-19 and Persistent Depression with/without Other Neuropsychiatric Symptoms |
| Keywords: |
COVID, depression, coronavirus, COVID-19, BHIC |
| Study Area: |
|
